Chronic News and Research

RSS

Oxis Biotech executes worldwide license agreement to develop, commercialize novel cancer therapy

Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.

8 Sep 2015

FDA grants Orphan Drug designation to Rigel's Fostamatinib for treatment of patients with ITP

Rigel Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has granted Orphan Drug designation to Fostamatinib, Rigel's oral spleen tyrosine kinase (SYK) inhibitor which is currently in Phase 3 clinical studies in patients with chronic immune thrombocytopenic purpura (ITP).

8 Sep 2015

IRIDEX launches novel intra-ocular pressure monitoring device

IRIDEX Corporation today announced that it has added a novel intra-ocular pressure (IOP) monitoring device called a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to IRIDEX through a distribution agreement with Icare Finland Plc, a subsidiary of the Revenio Group Corporation, the creator of the tonometer.

8 Sep 2015

DCR launches Biospecimen Research Grant Program

DaVita Clinical Research, a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen Research Grant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research.

8 Sep 2015

AMRA, Pfizer collaborate to assess fat and muscle measurements to predict obesity, diabetes

AMRA announced that they have entered into a unique international collaboration with Pfizer Inc. to investigate the relationship between fat and muscle distribution in the body and metabolic health, including risk factors for conditions such as obesity and diabetes.

8 Sep 2015

Journal of Medical Regulation publishes 2014 census of U.S. physician workforce

The Journal of Medical Regulation has published the "Census of Actively Licensed Physicians in the United States, 2014," which provides an analysis of the most recent physician licensure data collected from each of the state medical boards in the United States by the Federation of State Medical Boards (FSMB).

4 Sep 2015

Simple checklist to help parents determine their children’s school environment

Grassroots Environmental Education, a science-based environmental health non-profit organization based in New York, has issued a simple three-point checklist for parents of school-age children to help them determine if their child's school environment is as healthy as it can be.

4 Sep 2015

Current school and university start times linked to poor learning, health problems

A study by researchers from the University of Oxford, Harvard Medical School and the University of Nevada has found that current school and university start times are damaging the learning and health of students.

4 Sep 2015

HBV DNA levels guide antiviral treatment in chemotherapy setting

Pretreatment levels of hepatitis B virus DNA could inform the withdrawal of pre-emptive antiviral therapy in chronic HBV patients undergoing cytotoxic chemotherapy for cancer, indicate research findings published in Digestive Diseases and Sciences.

3 Sep 2015

Countrywide variations in chronic HBV burden revealed

A systematic review of the worldwide prevalence of chronic hepatitis B virus infection finds wide variation between countries.

3 Sep 2015

Risk score predicts ACLF risk in chronic HBV patients

A risk score incorporating routinely collected clinical information can identify patients with chronic hepatitis B virus infection at high risk of developing acute-on-chronic liver failure following severe acute exacerbation, research suggests.

3 Sep 2015

Common drug used for treating fungal infections in lung transplant recipients increases risk for skin cancer, death

Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UC San Francisco researchers.

3 Sep 2015

Imetelstat drug shows promise in treating patients with myelofibrosis

Imetelstat, a novel drug that targets telomerase, has demonstrated potential value in treating patients with myelofibrosis, according to the results of a study published today in the New England Journal of Medicine.

3 Sep 2015

Exercise training improves quality of life for patients with pulmonary hypertension

Exercise training for patients with pulmonary hypertension was shown to be safe and to improve quality of life, according to an analysis by UT Southwestern Medical Center cardiologists of studies involving more than 400 participants.

3 Sep 2015

Household food insecurity increases likelihood of metabolic diseases in children

New research indicates that household food insecurity dramatically increases the likelihood of metabolic diseases in children, with many showing chronic disease markers before they graduate from high school.

3 Sep 2015

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

A research team led by Kezhong Zhang, Ph.D., at the Wayne State University School of Medicine's Center for Molecular Medicine and Genetics, has discovered that exposure to air pollution has a direct adverse health effect on the liver and causes liver fibrosis, an illness associated with metabolic disease and liver cancer.

3 Sep 2015

TMIGD1 protein could be a novel target for restoring kidney function from kidney disease

A new discovery by Boston University School of Medicine (BUSM) researchers may change how kidney disease is treated in the future.

3 Sep 2015

World leaders meet at World Hepatitis Summit to discuss prevention strategies for viral hepatitis

Today marks the start of the first-ever World Hepatitis Summit hosted in Glasgow, Scotland, at the Scottish Exhibition and Conference Centre.

3 Sep 2015

Researchers develop new method that can target drug delivery to the lung

Researchers from Columbia Engineering and Columbia University Medical Center have developed a new method that can target delivery of very small volumes of drugs into the lung.

3 Sep 2015

Amgen announces MAA submission to EMA for novel calcimimetic agent etelcalcetide

Amgen today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency via the centralized procedure for etelcalcetide (formerly AMG 416) for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on hemodialysis therapy. If approved, etelcalcetide will be the first calcimimetic agent that can be administered intravenously.

3 Sep 2015

Chronic News and Research

Oxis Biotech executes worldwide license agreement to develop, commercialize novel cancer therapy

FDA grants Orphan Drug designation to Rigel's Fostamatinib for treatment of patients with ITP

IRIDEX launches novel intra-ocular pressure monitoring device

DCR launches Biospecimen Research Grant Program

AMRA, Pfizer collaborate to assess fat and muscle measurements to predict obesity, diabetes

Journal of Medical Regulation publishes 2014 census of U.S. physician workforce

Simple checklist to help parents determine their children’s school environment

Current school and university start times linked to poor learning, health problems

HBV DNA levels guide antiviral treatment in chemotherapy setting

Countrywide variations in chronic HBV burden revealed

Risk score predicts ACLF risk in chronic HBV patients

Common drug used for treating fungal infections in lung transplant recipients increases risk for skin cancer, death

Imetelstat drug shows promise in treating patients with myelofibrosis

Exercise training improves quality of life for patients with pulmonary hypertension

Household food insecurity increases likelihood of metabolic diseases in children

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

TMIGD1 protein could be a novel target for restoring kidney function from kidney disease

World leaders meet at World Hepatitis Summit to discuss prevention strategies for viral hepatitis

Researchers develop new method that can target drug delivery to the lung

Amgen announces MAA submission to EMA for novel calcimimetic agent etelcalcetide

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News